Efficacy of Disulfiram and Cognitive Behavior Therapy in Cocaine-dependent Outpatients: a Randomized Placebo-controlled Trial

Overview

Journal Arch Gen Psychiatry

Specialty Psychiatry

Date 2004 Mar 3

PMID 14993114

Citations 174

Authors

Kathleen M Carroll

Lisa R Fenton

Samuel A Ball

Charla Nich

Tami L Frankforter

Julia Shi

Bruce J Rounsaville

Affiliations

Soon will be listed here.

Abstract

Context: Disulfiram has emerged as a promising treatment for cocaine dependence, but it has not yet been evaluated in general populations of cocaine users.

Objectives: To compare the effectiveness of disulfiram therapy with that of a placebo condition in reducing cocaine use and to compare the effectiveness of 2 active behavioral therapies-cognitive behavior therapy (CBT) and interpersonal psychotherapy (IPT)-in reducing cocaine use.

Design: Randomized, placebo-controlled, double-masked (for medication condition), factorial (2 x 2) trial with 4 treatment conditions: disulfiram plus CBT, disulfiram plus IPT, placebo plus CBT, and placebo plus IPT.

Setting: A community-based outpatient substance abuse treatment program.

Patients: A total of 121 individuals meeting the criteria for current cocaine dependence.

Interventions: Patients received either disulfiram (250 mg/d) or placebo in identical capsules. Medication compliance was monitored using a riboflavin marker procedure. Both behavioral therapies (CBT and IPT) were manual guided and were delivered in individual sessions for 12 weeks.

Main Outcome Measures: Random regression analyses of self-reported frequency of cocaine use and results of urine toxicology screens.

Results: Participants assigned to disulfiram reduced their cocaine use significantly more than those assigned to placebo, and those assigned to CBT reduced their cocaine use significantly more than those assigned to IPT (P<.01 for both). Findings were consistent across all study samples (eg, intention to treat, treatment initiators, and treatment completers). Benefits of disulfiram use and CBT were most pronounced for participants who were not alcohol dependent at baseline or who fully abstained from drinking alcohol during treatment. Adverse effects experienced by participants who received disulfiram were mild and were not considerably different from those experienced by participants who received placebo.

Conclusions: Disulfiram and CBT are effective therapies for general populations of cocaine-dependent individuals. Disulfiram seems to exert a direct effect on cocaine use rather than through reducing concurrent alcohol use.

Citing Articles

Efficacy of Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT) in Individuals With Chronic Pain and Opioid Use Disorder: Protocol for a Randomized Clinical Trial of a Digital Cognitive Behavioral Treatment.

MacLean R, Ankawi B, Driscoll M, Gordon M, Frankforter T, Nich C JMIR Res Protoc. 2024; 13:e54342.

PMID: 38506917 PMC: 10993119. DOI: 10.2196/54342.

Psychosocial interventions for stimulant use disorder.

Minozzi S, Saulle R, Amato L, Traccis F, Agabio R Cochrane Database Syst Rev. 2024; 2:CD011866.

PMID: 38357958 PMC: 10867898. DOI: 10.1002/14651858.CD011866.pub3.

Disulfiram for the treatment of cocaine dependence.

Traccis F, Minozzi S, Trogu E, Vacca R, Vecchi S, Pani P Cochrane Database Syst Rev. 2024; 1:CD007024.

PMID: 38180268 PMC: 10767770. DOI: 10.1002/14651858.CD007024.pub3.

Percentage of negative urine drug screens as a clinically meaningful endpoint for RCTs evaluating treatment for cocaine use.

Loya J, Babuscio T, Nich C, Alessi S, Rash C, Kiluk B Drug Alcohol Depend. 2023; 248:109947.

PMID: 37276806 PMC: 10498479. DOI: 10.1016/j.drugalcdep.2023.109947.

Disulfiram: Mechanisms, Applications, and Challenges.

Lanz J, Biniaz-Harris N, Kuvaldina M, Jain S, Lewis K, Fallon B Antibiotics (Basel). 2023; 12(3).

PMID: 36978391 PMC: 10044060. DOI: 10.3390/antibiotics12030524.

References

Higgins S, Budney A, Bickel W, Hughes J, Foerg F . Disulfiram therapy in patients abusing cocaine and alcohol. Am J Psychiatry. 1993; 150(4):675-6. DOI: 10.1176/ajp.150.4.675b. View

Gibbons R, Hedeker D, Elkin I, Waternaux C, Kraemer H, Greenhouse J . Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry. 1993; 50(9):739-50. DOI: 10.1001/archpsyc.1993.01820210073009. View

Carroll K, Rounsaville B, Gordon L, Nich C, Jatlow P, Bisighini R . Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry. 1994; 51(3):177-87. DOI: 10.1001/archpsyc.1994.03950030013002. View

Carroll K, Rounsaville B, Nich C . Blind man's bluff: effectiveness and significance of psychotherapy and pharmacotherapy blinding procedures in a clinical trial. J Consult Clin Psychol. 1994; 62(2):276-80. DOI: 10.1037//0022-006x.62.2.276. View

Zanis D, McLellan A, Randall M . Can you trust patient self-reports of drug use during treatment?. Drug Alcohol Depend. 1994; 35(2):127-32. DOI: 10.1016/0376-8716(94)90119-8. View

Ehrman R, Robbins S . Reliability and validity of 6-month timeline reports of cocaine and heroin use in a methadone population. J Consult Clin Psychol. 1994; 62(4):843-50. DOI: 10.1037//0022-006x.62.4.843. View

Carroll K, Rounsaville B, Nich C, Gordon L, Wirtz P, Gawin F . One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects. Arch Gen Psychiatry. 1994; 51(12):989-97. DOI: 10.1001/archpsyc.1994.03950120061010. View

Stout R, Wirtz P, Carbonari J, Del Boca F . Ensuring balanced distribution of prognostic factors in treatment outcome research. J Stud Alcohol Suppl. 1994; 12:70-5. DOI: 10.15288/jsas.1994.s12.70. View

McCance E, Price L, Kosten T, Jatlow P . Cocaethylene: pharmacology, physiology and behavioral effects in humans. J Pharmacol Exp Ther. 1995; 274(1):215-23. View

10.

Hameedi F, Rosen M, McMahon T, Price L, Jatlow P, Woods S . Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans. Biol Psychiatry. 1995; 37(8):560-3. DOI: 10.1016/0006-3223(94)00361-6. View

11.

Brady K, Sonne S, Randall C, Adinoff B, Malcolm R . Features of cocaine dependence with concurrent alcohol abuse. Drug Alcohol Depend. 1995; 39(1):69-71. DOI: 10.1016/0376-8716(95)01128-l. View

12.

Higgins S, Roll J, Bickel W . Alcohol pretreatment increases preference for cocaine over monetary reinforcement. Psychopharmacology (Berl). 1996; 123(1):1-8. DOI: 10.1007/BF02246274. View

13.

Del Boca F, Kranzler H, Brown J, Korner P . Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcohol Clin Exp Res. 1996; 20(8):1412-7. DOI: 10.1111/j.1530-0277.1996.tb01142.x. View

14.

Schmitz J, Bordnick P, Kearney M, Fuller S, Breckenridge J . Treatment outcome of cocaine-alcohol dependent patients. Drug Alcohol Depend. 1997; 47(1):55-61. DOI: 10.1016/s0376-8716(97)00069-0. View

15.

McKay J, Alterman A, Cacciola J, Rutherford M, OBrien C, Koppenhaver J . Group counseling versus individualized relapse prevention aftercare following intensive outpatient treatment for cocaine dependence: initial results. J Consult Clin Psychol. 1997; 65(5):778-88. DOI: 10.1037//0022-006x.65.5.778. View

16.

Carroll K . Manual-guided psychosocial treatment. A new virtual requirement for pharmacotherapy trials?. Arch Gen Psychiatry. 1997; 54(10):923-8. DOI: 10.1001/archpsyc.1997.01830220041007. View

17.

Kosten T, Jatlow P . Chronic disulfiram treatment effects on intranasal cocaine administration: initial results. Biol Psychiatry. 1998; 43(7):540-3. DOI: 10.1016/S0006-3223(97)00506-4. View

18.

Carroll K, Connors G, Cooney N, DiClemente C, Donovan D, Kadden R . Internal validity of Project MATCH treatments: discriminability and integrity. J Consult Clin Psychol. 1998; 66(2):290-303. DOI: 10.1037//0022-006x.66.2.290. View

19.

Carroll K, Nich C, Ball S, MCCANCE E, Rounsavile B . Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction. 1998; 93(5):713-27. DOI: 10.1046/j.1360-0443.1998.9357137.x. View

20.

Kosten T, Jatlow P . Disulfiram effects on acute cocaine administration. Drug Alcohol Depend. 1998; 52(1):27-39. DOI: 10.1016/s0376-8716(98)00050-7. View